Editas Medicine, Inc. (EDIT) › Operating IncomeEditas Medicine, Inc. (EDIT) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2014: -$12.72M2015: -$35.31M2016: -$97.19M2017: -$119.93M2018: -$113.73M2019: -$140.92M2020: -$134.84M2021: -$193.15M2022: -$225.95M2023: -$169.18M2024: -$251.15M2025: -$160.01M-$160.01M2014Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$160.01M+36.3%2024-$251.15M-48.5%2023-$169.18M+25.1%2022-$225.95M-17.0%2021-$193.15M-43.2%2020-$134.84M+4.3%2019-$140.92M-23.9%2018-$113.73M+5.2%2017-$119.93M-23.4%2016-$97.19M-175.2%2015-$35.31M-177.5%2014-$12.72M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share